| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.42 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |